Micronucleus frequency in lymphocytes and 8-hydroxydeoxyguanosine level in plasma of women with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 26, Issue 8, 2010, Pages 590-595

  Hamurcu, Zuhal ^a   Bayram, Fahri ^a   Kahriman, Güven ^b   Dönmez Altuntas, Hamiyet ^a   Baskol, Glden ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b Erciyes Medical School   (Turkey)

Author keywords

8 hydroxydeoxyguanosine; genomic damage; micronucleus; Polycystic ovary syndrome

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHROMOSOME DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINESIS; DISEASE ASSOCIATION; DNA DAMAGE; FEMALE; GENE FREQUENCY; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MICRONUCLEUS; MICRONUCLEUS TEST; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; CHROMOSOME BREAKAGE; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHROMOSOME BREAKAGE; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; HUMANS; MICRONUCLEUS TESTS; OXIDATIVE STRESS; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 77954770851     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513591003632142     Document Type: Article

References (38)

1. Frank S. Polycystic ovary syndrome. N Engl J Med 1995; 333:853-861.
2. Gadducci A, Gargini A, Palla E, Fanucchi A, Genazzani AR. Polycystic ovary syndrome and gynecological cancers: is there a link? Gynecol Endocrinol 2005;20:200-208.
3. Xita N, Georgiou I, Tsatsoulis A. The genetic basis of polycystic ovary syndrome. Eur J Endocrinol 2002;147:717-725.
4. Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003;361: 1810-1812. (Pubitemid 36638434)
5. Lobo RA, Carmina E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 2000;132:989-993.
6. Elmasry K, Gayther SA. Ovarian cancer aetiology: facts and fiction. J Fam Plann Reprod Health Care 2006;32:82-86.
7. Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update 2001;7:522-525.
8. Navaratnarajah R, Pillay OC, Hardiman P. Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med 2008; 26:62-71.
9. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, et al. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 2007;28:625-631.
10. Floyd RA. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 1990;11:1447-1450.
11. Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsière T. Genetic polymorphisms and micronucleus formation: a review of the literature. Mutat Res 2008;658:215-233.
12. Fenech M. The genome health clinic and genome health nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis 2005;20:255-269.
13. Mateuca R, Lombaert N, Aka PV, Decordier I, Kirsch-Volders M. Chromosomal changes: induction, detection methods and applicability in human biomonitoring. Biochimie 2006;88:1515-1531.
14. Halliwell B, Aruoma OI. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett 1991;281:9-19.
15. Stopper H, Schupp N, Bahner U, Sebekova K, Klassen A, Heidland A. Genomic damage in end-stage renal failure: potential involvement of advanced glycation end products and carbonyl stress. Semin Nephrol 2004;24:474-478.
16. Calişkan-Can E, Firat H, ArdiçS, Simşek B, Torun M, Yardim-Akaydin S. Increased levels of 8-hydroxydeoxyguanosine and its relationship with lipid peroxidation and antioxidant vitamins in lung cancer. Clin Chem Lab Med 2008;46:107-112.
17. Chen HI, Liou SH, Ho SF, Wu KY, Sun CW, Chen MF, Cheng LC, Shih TS, Loh CH. Oxidative DNA damage estimated by plasma 8-hydroxyguanosine (8-OHdG): influence of 4, 4'-methylenebis (2-chloroaniline) exposure and smoking. J Occup Health 2007;49:389-398.
18. Dincer Y, Erzin Y, Himmetoglu S, Gunes KN, Bal K, Akcay T. Oxidative DNA damage and antioxidant activity in patients with inflammatory bowel disease. Dig Dis Sci 2007;52:1636-1641.
19. Sabuncu T, Vural H, HarmaM, HarmaM. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem 2001;34:407-413.
20. Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 2003;80:123-127.
21. Syndrome. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Fertil Steril 2004;81:19-25.
22. Fenech M, Morley AA. Measurement of micronuclei in lymphocytes. Mutat Res 1985;147:29-36.
23. Hamurcu Z, Donmez-Altuntas H, Patiroglu T. Basal level micronucleus frequency in stimulated lymphocytes of untreated patients with leukemia. Cancer Genet Cytogenet 2008;180:140-144.
24. Fenech M. The in vitro micronucleus technique. Mutat Res 2004;55:81-95.
25. Tsilchorozidou T, Overton C, Convay GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol 2004;60:1-17.
26. Goodarzi MO, Azziz R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2006;20:193-205. (Pubitemid 43842923)
27. Moran LJ, Noakes M, Clifton PM, Norman RJ, Fenech MF. Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance. Mutat Res 2008;639:55-63.
28. Yesilada E, Sahin I, Ozcan H, Y?ld?r?m IH, Yologlu S, Taskapan C. Increased micronucleus frequencies in peripheral blood lymphocytes in women with polycystic ovary syndrome. Eur J Endocrinol 2006;154:563-568.
29. Jagetia GC, Jayakrishnan A, Fernandes D, Vidyasagar MS. Evaluation of micronuclei frequency in cultured peripheral blood lymphocytes of cancer patients before and after radiation treatment. Mutat Res 2001;491:9-16.
30. Rosin MP, German J. Evidence for chromosome instability in vivo bloom syndrome: increased numbers of micronuclei in exfoliated cells. Hum Genet 1985;71:187-191.
31. Ames BN, Gold LS, WilletWC. The causes and prevention of cancer. Proc Natl Acad Sci USA 1995;92:5258-5265.
32. Yared E, McMillan TJ, Martin FL. Genotoxic effects of oestrogens in breast cells detected by the micronucleus assay and comet assay. Mutagenesis 2002;17:345-352.
33. Kabil A, Silva E, Kortenkamp A. Estrogens and genomic instability in human breast cancer cells-involvement of Src/ Raf/Erk signaling in micronucleus formation by estrogenic chemicals. Carcinogenesis 2008;29:1862-1868.
34. Rojanasakul A, Gustavson KH, Lithell H, Nillius SJ. Tetraploidy in two sisters with the polycystic ovary syndrome. Clin Genet 1985;27:167-174.
35. Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S. The Human Micronucleus Project - an international collaborative study on the use of micronucleus technique for measuring DNA damage in humans. Mutat Res 1999;428:271-283.
36. Baciuchka-Palmaro M, Orsière T, Duffaud F, Sari-Minodier I, Pompili J, Bellon L, De Méo M, Digue L, Favre R, Botta A. Acentromeric micronuclei are increased in peripheral blood lymphocytes of untreated cancer patients. Mutat Res 2002;520:189-198.
37. Peng T, Shen HM, Liu ZM, Yan LN, Peng MH, Li LQ, Liang RX, Wei ZL, Halliwell B, Ong CN. Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGG1: a study of adolescents in a high risk region for hepatocellular carcinoma in China. World J Gastroenterol 2003;9:2186-2193.
38. Luan Y, Suzuki T, Palanisamy R, Takashima Y, Sakamoto H, Sakuraba M, Koizumi T, Saito M, Matsufuji H, Yamagata K, et al. Potassium bromate treatment predominantly causes large deletions, but not GC4TA transversion in human cells. Mutat Res 2007;619:113-123.